Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13B |
| 2 |
Eaton
ETN
|
+$1.11B |
| 3 |
Analog Devices
ADI
|
+$867M |
| 4 |
Progressive
PGR
|
+$792M |
| 5 |
Datadog
DDOG
|
+$693M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.7B |
| 2 |
NVIDIA
NVDA
|
+$1.45B |
| 3 |
Salesforce
CRM
|
+$1.22B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 5 |
lululemon athletica
LULU
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
iShares Russell 1000 Growth ETF
IWF
$121B
| $11.4M | 0.01% |
125,348
-4,148
| -3% | -$354K |
|
|
GTLS
377
DELISTED
Chart Industries
GTLS
| $11.4M | 0.01% |
78,713
-65
| -0.1% | -$9.81K |
|
378
MaxLinear
MXL
$6.06B
| $10.9M | 0.01% |
539,255
+5,839
| +1% | +$115K |
|
379
KKR & Co
KKR
$91.1B
| $10.6M | 0.01% |
100,780
-108
| -0.1% | -$11K |
|
380
Unilever
UL
$137B
| $10.6M | 0.01% |
170,625
-803
| -0.5% | -$47.5K |
|
381
BCE
BCE
$20.2B
| $10.4M | 0.01% |
321,757
-6,836
| -2% | -$228K |
|
382
Option Care Health
OPCH
$3.45B
| $10.3M | 0.01% |
373,135
-9,434
| -2% | -$281K |
|
383
Concrete Pumping Holdings
BBCP
$490M
| $9.98M | 0.01% |
1,660,117
+2,952
| +0.2% | +$20.4K |
|
384
Vesta Real Estate
VTMX
$3.2B
| $9.82M | 0.01% |
327,537
-2,243
| -0.7% | -$78.4K |
|
385
Stantec
STN
$8.04B
| $9.8M | 0.01% |
116,988
+24,740
| +27% | +$2.02M |
|
386
State Street SPDR S&P Metals & Mining ETF
XME
$3.87B
| $9.73M | 0.01% |
164,075
+20,602
| +14% | +$1.26M |
|
387
Lifestance Health
LFST
$4B
| $9.58M | 0.01% |
1,952,046
+13,723
| +0.7% | +$82.7K |
|
388
Corning
GLW
$119B
| $9.54M | 0.01% |
245,563
-5,195
| -2% | -$181K |
|
389
Elanco Animal Health
ELAN
$13.2B
| $9.12M | 0.01% |
+632,096
| New | +$10.1M |
|
390
Bilibili
BILI
$7.99B
| $9.05M | 0.01% |
+586,091
| New | +$8.17M |
|
391
Sanofi
SNY
$103B
| $8.9M | 0.01% |
183,473
-6,149
| -3% | -$297K |
|
392
Kodiak Gas Services
KGS
$5.92B
| $8.86M | 0.01% |
325,044
+135,433
| +71% | +$3.68M |
|
393
American Tower
AMT
$80.8B
| $8.75M | 0.01% |
45,033
-4,407,573
| -99% | -$824M |
|
394
Veracyte
VCYT
$3.7B
| $8.69M | 0.01% |
401,084
-10,456
| -3% | -$220K |
|
395
Materion
MTRN
$4.39B
| $8.57M | 0.01% |
79,292
-182,829
| -70% | -$21M |
|
396
Ovintiv
OVV
$17.3B
| $8.49M | 0.01% |
181,243
+59,193
| +48% | +$2.98M |
|
397
Bunge Global
BG
$20.4B
| $8.39M | 0.01% |
78,601
+320
| +0.4% | +$33.6K |
|
398
Intuit
INTU
$86.5B
| $8.27M | 0.01% |
12,591
+5,690
| +82% | +$3.53M |
|
399
Dow Inc
DOW
$21.9B
| $8.23M | 0.01% |
155,195
+12,549
| +9% | +$717K |
|
400
First Solar
FSLR
$22.7B
| $8.21M | 0.01% |
+36,395
| New | +$7.93M |
|
Similar funds
Jennison Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Jennison Associates held 620 positions worth $156B, up 4.3% from $150B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates's Q2 2024 filing shows 48 new, 288 increased, 229 reduced and 48 closed positions. Its largest new stake was Analog Devices: 4,062,204 shares worth $927M. The largest sale was UnitedHealth, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2024 buy was Analog Devices: 4,062,204 shares worth $927M.
- Jennison Associates added most to Apple in Q2 2024, an estimated $2.13B increase.
- Jennison Associates's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.7B.
- Jennison Associates fully exited Estee Lauder in Q2 2024, selling an estimated $291M.
- Jennison Associates's ten largest holdings make up 48% of its $156B portfolio in Q2 2024.
- Jennison Associates opened 48 new positions and closed 48 in Q2 2024.
- Jennison Associates's portfolio value rose 4.3% quarter-over-quarter to $156B.
Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.